To the Editor: We read with considerable puzzlement Dr Levis' critique of our case report conclusion that armadillos infected with Mycobacterium leprae were the likely source of our patients' Hansen's disease. We believe that both the clinical and genotypic evidence that the armadillo is an important vector for Hansen's disease in Florida is quite overwhelming.
Dr Levis' statement that ''It is incumbent on your journal to not assume such cases are from armadillos especially when there is no history of armadillo exposure'' (our emphasis) completely ignores the facts of 2 of the cases we report. In both cases, the 2 patients had actually handled armadillo carcasses. In our opinion, it is quite absurd to consider this most unusual extraordinarily close contact with armadillos a mere coincidence in these patients subsequently developing leprosy. But not only is Dr Levis ignoring these important historic facts in these 2 patients, he is also overlooking the excellent study published by Sharma et al 1 last year. In this careful and important publication, Sharma et al 1 report on the molecular ( genetic) studies Dr Levis claims are lacking. They published in this study that armadillos over a 4-state area in the Southern United States including Florida were infected with M leprae of the same genotype as 42% of M lepraeeinfected patients in these same states. Again, this is highly unlikely to be yet another coincidence and certainly would have nothing to do with the 14% foreign-born travelers in Florida that Dr Levis is erroneously suggesting explains these leprosy cases. There is no evidence to support this supposition.
We strongly suggest that the combination of the rapid increase of the incidence of leprosy in Florida, in conjunction with the rapid increase of infected armadillos (documented by Sharma et al 1 ) , and the genetic identity of M lepraeeinfected armadillos with the same genotype of M leprae infecting Florida patients, offers compelling evidence of the armadillo as the vector for many of the Florida leprosy cases. Additionally, our report of 2 patients with no travel history and no known contact with other leprosy patients and with close direct contact with armadillos coincident with their development of leprosy (3-4 years after contact), provides yet further convincing evidence of this emerging zoonosis in the southeast United States.
We again emphasize that it is important for clinicians in Florida and the southeast United States to be aware of this emerging zoonosis and, even when there is no travel history, to consider leprosy in the differential diagnosis for patients in Florida with progressive neuropathy so that irreversible neuropathy (as seen in 2 of our patients) can be avoided by earlier diagnosis. Because 2 of our patients who had no contact with armadillos but were avid gardeners on land inhabited by armadillos, we would also echo the admonition of Sharma et al 1 that ''persons concerned about exposure to M leprae from armadillos in their environment might be advised to wear gloves while gardening or use similar general hygienic practices commonly recommended for avoiding exposure to other pathogens in the environment.'' This is a topic that certainly still remains unclear and warrants further investigation.
We express our appreciation to the Journal of the American Academy of Dermatology Case Reports editorial board for publishing this important information. We respectfully thank Dr Levis for his expertise, interest, and critique of our case report. It does seem likely that although his autochthonous New York City cases are probably from international travel, for the compelling reasons outlined above, we strongly do not believe that is the case in Florida. Here, a significant number of these autochthonous cases are likely from the many infected armadillos whose M leprae genotypes are shared by many of the infected patients here and, therefore, most likely represent an emerging zoonosis in Florida. 
